The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
NeuroPharma raises $190M Series B in September 2025 funding round
NeuroPharma secures $190M in Series B funding in September 2025, reaching $1.6B valuation to advance its neurological drug discovery using ai and machine learning.
BioSynth Labs raises $380M Series B in September 2025 funding round
BioSynth Labs secures $380M in Series B funding in September 2025, reaching $3.2B valuation to advance its synthetic biology platform for sustainable chemical manufacturing.
EcoMaterials raises $150M Series B in September 2025 funding round
EcoMaterials secures $150M in Series B funding in September 2025, reaching $1.5B valuation to advance its sustainable materials manufacturing using biotechnology.
MetaCommerce raises $180M Series B in September 2025 funding round
MetaCommerce secures $180M in Series B funding in September 2025, reaching $1.9B valuation to advance its virtual reality shopping platform for immersive e-commerce.
UrbanFlow raises $180M Series B in September 2025 funding round
UrbanFlow secures $180M in Series B funding in September 2025, reaching $1.8B valuation to advance its smart city traffic optimization and urban mobility platform.
CloudNative Security raises $110M Series B in September 2025 funding round
CloudNative Security secures $110M in Series B funding in September 2025, reaching $950M valuation to advance its container and kubernetes security platform for devops teams.
MindBridge AI raises $95M Series B in September 2025 funding round
MindBridge AI secures $95M in Series B funding in September 2025, reaching $800M valuation to advance its ai-powered personalized learning platform for professional development.
TeleHealth Plus raises $130M Series B in September 2025 funding round
TeleHealth Plus secures $130M in Series B funding in September 2025, reaching $1.1B valuation to advance its comprehensive telehealth platform with ai-powered diagnostics.
HealthAI Diagnostics raises $210M Series B in September 2025 funding round
HealthAI Diagnostics secures $210M in Series B funding in September 2025, reaching $2.1B valuation to advance its ai-powered medical imaging and diagnostic platform.
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.